Cannabinoid-induced motor dysfunction via autophagy inhibition.

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Cannabis use is increasing globally for medical and recreational purposes.
• Cannabis use can lead to adverse side effects, necessitating research into its harms.
• Cannabinoid receptor 1 (CNR1/CB₁R) is implicated in autophagy in cultured cells, but its role in vivo is unknown.

Purpose of the Study:

• To investigate whether CNR1 controls autophagy in the mouse brain in vivo.
• To determine the functional consequences of a potential CNR1-autophagy connection.
• To explore potential therapeutic strategies for cannabis-evoked motor impairments.

Main Methods:

• Administration of Δ⁹-tetrahydrocannabinol (THC) to mice.
• Assessment of autophagy levels in the mouse striatum.
• Treatment with autophagy activators (temsirolimus, trehalose).
• Utilizing genetic strategies in vivo to target CNR1 on specific neuronal pathways.

Main Results:

• THC impairs autophagy in the mouse striatum.
• Autophagy activators reversed THC-induced autophagy inhibition and motor deficits.
• CNR1 on neurons in the direct (striatonigral) pathway is essential for THC's effects on autophagy and motor function.

Conclusions:

• Autophagy is a mechanistic link between THC and motor performance.
• Targeting autophagy may offer a novel therapeutic approach for managing cannabis-induced motor impairments.
• Findings provide a new perspective on the neurobiological mechanisms of cannabis action.